Research output per year
Research output per year
Organization profile
Organization profile
The Cancer Epigenetics Institute (CEI) at Fox Chase is a national hub for epigenetics study and collaboration that is focused on mechanisms promoting cancer and therapeutic resistance. CEI aims to promote fundamental discovery in cancer epigenetics, while identifying novel biomarkers and therapeutic targets. Its mission is to translate these scientific insights into a positive impact on patients by facilitating academic-to-industry and academic-to-academic partnerships. Johnathan R. Whetstine, PhD, leads Fox Chase's Cancer Epigenetics Instiute.
Fingerprint
Dive into the research topics where Cancer Epigenetics Institute is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Autophagy in cancer development, immune evasion, and drug resistance
Niu, X., You, Q., Hou, K., Tian, Y., Wei, P., Zhu, Y., Gao, B., Ashrafizadeh, M., Aref, A. R., Kalbasi, A., Cañadas, I., Sethi, G., Tergaonkar, V., Wang, L., Lin, Y., Kang, D. & Klionsky, D. J., Jan 2025, In: Drug Resistance Updates. 78, 101170.Research output: Contribution to journal › Review article › peer-review
8 Scopus citations -
Brief Report: Not Created Equal: Survival Differences by KRAS Mutation Subtype in NSCLC Treated With Immunotherapy
Sun, L., Zhou, Y., Handorf, E. A., Borghaei, H., Bauman, J. & Aggarwal, C., Jan 2025, In: JTO Clinical and Research Reports. 6, 1, p. 100755 100755.Research output: Contribution to journal › Article › peer-review
Open Access -
Comparison of Outcomes Between African American and European American Patients With Metastatic Clear Cell Renal Cell Carcinoma Receiving Immune Checkpoint Inhibitors
Kaur, J., Hasler, J. S., Handorf, E. A., Zibelman, M. R., Anari, F., Geynisman, D. M. & Ghatalia, P., Apr 2025, In: Clinical Genitourinary Cancer. 23, 2, p. 102304 102304.Research output: Contribution to journal › Article › peer-review
Prizes
-
Fellow of the American Society of Clinical Oncology
Plimack, E. R. (Recipient), Nov 9 2023
Prize: Other distinction
-
-
Press/Media
-
GO2 for Lung Cancer Forms the Global Advisory Council to Support Its Mission to Confront Lung Cancer
03/25/25
13 items of Media coverage
Press/Media
-
Data on Dermatofibrosarcomas Reported by Researchers at Fox Chase Cancer Center (Examining the Impact of Biopsy Technique On Clinical and Pathologic Outcomes In Dermatofibrosarcoma Protuberans: an International, Multi-institutional Study)
Hasler, J. S., Greco, S. H., von Mehren, M. & Farma, J. M.
03/21/25
1 item of Media coverage
Press/Media
-
Adjuvant nivolumab delivers in muscle-invasive bladder cancer
03/9/25
1 item of Media coverage
Press/Media
Equipment
-
Biological Imaging Facility
Gligorijevic, PhD, B. (Director), Johnson, PhD, N. (Director), Efimov, PhD, A. (Manager) & Yang, PhD, Y. (Manager)
Equipment/facility: Facility
-